XML 16 R7.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Cash flows from operating activities:      
Net loss $ (2,951) $ (3,434)  
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:      
Goodwill and intangible asset impairment charge 0 0  
Depreciation 48 72  
Amortization of intangible assets 161 260  
Amortization of capitalized software development costs 84 83  
Amortization of deferred financing costs 7 3  
Amortization of debt discount 303 129  
Loss on debt settled in shares 106 0  
Stock-based compensation expense 285 408  
Credit loss expense 32 0  
Change in fair value of derivative instruments, net (69) 581  
Deferred income taxes 2 55  
Changes in assets and liabilities:      
Contract receivables, net (486) 846  
Prepaid expenses and other assets 876 943  
Accounts payable, accrued compensation and accrued expenses 1,252 1,028  
Billings in excess of revenue earned (61) 150  
Accrued warranty (94) 15  
Other liabilities (336) (56)  
Net cash (used in) provided by operating activities (841) 1,083  
Cash flows from investing activities:      
Capital expenditures 0 (81)  
Capitalized software development costs (77) (106)  
Net cash used in investing activities (77) (187)  
Cash flows from financing activities:      
Repayment of line of credit 0 (1,817)  
Repayment of insurance premium financing (243) (282)  
Proceeds from issuance of long-term debt and warrants 0 5,750  
Payments of debt issuance and original discount on issuance of long-term debt and warrants 0 (968)  
Principal repayment of convertible note (319) 0  
Tax paid for shares withheld (58) (86)  
Net cash (used in) provided by financing activities (620) 2,597  
Effect of exchange rate changes on cash 5 (12)  
Net (decrease) increase in cash, cash equivalents and restricted cash (1,533) 3,481  
Cash, cash equivalents and restricted cash at beginning of the period 4,376 3,550 $ 3,550
Cash, cash equivalents and restricted cash at the end of the period 2,843 7,031 4,376
Cash and cash equivalents 1,265 5,448 2,789
Restricted cash, current 500 0 1,052
Restricted cash included in other long-term assets 1,078 1,583 535
Total cash, cash equivalents and restricted cash 2,843 7,031 $ 4,376
Non-cash financing activities      
Repayment of convertible note in shares 745 0  
Discount on issuance of convertible note $ 0 $ 750